SillaJen (XKRX:215600) Short-Term Debt : ₩9,705 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SillaJen Short-Term Debt?

SillaJen's Short-Term Debt for the quarter that ended in Dec. 2024 was ₩9,705 Mil.

SillaJen's quarterly Short-Term Debt increased from Jun. 2024 (₩8,882 Mil) to Sep. 2024 (₩9,285 Mil) and increased from Sep. 2024 (₩9,285 Mil) to Dec. 2024 (₩9,705 Mil).

SillaJen's annual Short-Term Debt declined from Dec. 2022 (₩7,594 Mil) to Dec. 2023 (₩0 Mil) but then increased from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩9,705 Mil).

SillaJen Short-Term Debt Historical Data

The historical data trend for SillaJen's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SillaJen Short-Term Debt Chart

SillaJen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

10,002.14

7,594.12

9,705.39

SillaJen Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															-	-	8,881.92	9,284.53	9,705.39

SillaJen Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

SillaJen Short-Term Debt Related Terms

Thank you for viewing the detailed overview of SillaJen's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

SillaJen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274

Website

http://www.sillajen.com

SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines